Fagron NV (ARSUF) Q2 2026 Earnings Call Transcript

We're pleased to report a strong performance with revenues reaching EUR 552 million. This reflects 3.1% organic growth at CER, 7% when normalizing the GLP-1 effect. Growth was driven by brands, Latin America, B&E North America and EMEA. Profitability grew by 12.7% to EUR 107 million. The margin of 19.4% reflects an improvement in both EMEA and Latin America and temporary effects in North America Pacific compounding services. On M&A, we closed the acquisition of Amber in Singapore and Malaysia, completing 5 acquisitions across all regions in 2026. We also entered into a collaboration agreement with NutraConnect in Asia, which will complement our nutraceutical platform. Integration of earlier announced acquisition remains on track. We have also appointed Amy Jones to lead the North